Seres Therapeutics
MCRB
MCRB
93 hedge funds and large institutions have $342M invested in Seres Therapeutics in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 41 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2% more call options, than puts
Call options by funds: $3.53M | Put options by funds: $3.45M
0.19% more ownership
Funds ownership: 4.76% → 4.96% (+0.19%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
93
Holding in Top 10
2
Calls
$3.53M
Puts
$3.45M
Top Buyers
| 1 | +$18.2M | |
| 2 | +$2.79M | |
| 3 | +$1.76M | |
| 4 |
D.E. Shaw & Co
New York
|
+$1.55M |
| 5 |
Renaissance Technologies
New York
|
+$1.51M |
Top Sellers
| 1 | -$4.85M | |
| 2 | -$4.78M | |
| 3 | -$1.94M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$689K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$257K |